HHS Secretary Robert F. Kennedy Jr. is preparing to name as many as eight new members to the U.S. Preventive Services Task Force, the influential and little-known federal panel that determines which preventive medical services — from mammograms to colonoscopies to cancer screenings — insurers must cover for free, with the newly reshaped panel set to hold its first meeting in 17 months this August.
A Long-Overdue Shake-Up, Supporters Say
Kennedy has repeatedly criticized the task force’s past performance, describing it at one point as “lackadaisical,” and has moved to remake the panel after blocking it from meeting on multiple occasions, declining to replace members whose terms expired, and removing its vice chairs in May. The task force, normally composed of 16 experts, has shrunk by half in recent months as Kennedy has worked to reconstitute it with new leadership.
Notably, the incoming selection process is reportedly favoring specialists over the primary care physicians who have traditionally filled these roles — a departure supporters say could bring fresh, more clinically focused perspectives to a panel that plays an outsized role in American healthcare.
What the Panel Actually Does
The task force’s recommendations carry real financial weight for patients. Services that receive the panel’s highest grades — “A” or “B” — must be covered by most private insurers and state Medicaid expansion programs without any copays or deductibles. That includes widely used preventive services like mammograms, colonoscopies, and pap tests, meaning changes in the panel’s composition and priorities could eventually ripple out to affect coverage decisions for millions of Americans.
Questions About the Process
The overhaul hasn’t been without scrutiny. Former task force members have said the process for selecting new members has been less transparent than in years past, and HHS has not detailed publicly why several previously completed recommendations have not yet been released. HHS says the August meeting was delayed due to an unusually high volume of nominations for the open seats, requiring more time to properly vet and onboard the incoming members.
Supporters of Kennedy’s approach argue that an independent-in-name-only panel benefits from new energy and accountability, especially given how directly its decisions affect what Americans pay out of pocket for basic preventive care, while critics continue to press for more transparency around how the new members are being chosen and what direction they intend to take the panel in.
This story is developing.
